Coronavirus: America’s drug supply needs a refill

Photo Credit: NY Daily News/Getty Images

The coronavirus outbreak that originated in China could put the health of millions of Americans at risk — but not in the way most people imagine. Since China is the world’s leading supplier of the active ingredients used in medications, the epidemic may lead to a massive shortage of prescription drugs, and generic drugs in particular.

This emerging threat sheds light on a much larger problem: America’s precarious generic-drug supply chain has made life-threatening medication shortages into a constant danger. Safeguarding access to critical medicines will require reforms that give drug manufacturers the financial incentive to keep these drugs in good supply.

Drug shortages aren’t anything new for the nation’s health system. But they have grown increasingly common in recent years. In 2019, for instance, a shortage of the childhood cancer drug vincristine jeopardized the care of young patients around the country. And the growing scarcity of the widely-used blood-thinner heparin — which is essential for performing heart surgery — has many hospitals preparing for an emergency.

 
Sign Up for Our Email Newsletter

RECENT NEWS

We Can Fight Fraud Without Threatening Access to Care

We Can Fight Fraud Without Threatening Access to Care

When Washington fails to police its own programs, it’s hardworking Americans that pay the price. ...  Read more

Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

There is something almost too neat—too polished—about the way not-for-profit hospitals tell their financial story. It is...  Read more

Modernizing North Carolina's Nonprofit Social Contract

Modernizing North Carolina's Nonprofit Social Contract

Nonprofit hospitals occupy a uniquely privileged position in the American healthcare system. Their exemption from federal...  Read more

DRUGWONKS BLOG